Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Dianthus Therapeutics, Inc. (DNTH) had Receiveable Turnover of 5.46 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.28M |
|
$-64.43M |
|
-- |
|
$0.28M |
|
$69.83M |
|
$-69.54M |
|
$5.11M |
|
$-64.43M |
|
$-64.69M |
|
$-64.43M |
|
$-64.43M |
|
$-64.43M |
|
$-64.69M |
|
$-69.54M |
|
$-70.30M |
|
38.62M |
|
38.62M |
|
$-1.53 |
|
$-1.53 |
|
| Balance Sheet Financials | |
$409.44M |
|
$0.30M |
|
$121.48M |
|
$530.92M |
|
$30.73M |
|
-- |
|
$6.79M |
|
$37.52M |
|
$493.40M |
|
$493.40M |
|
$493.40M |
|
43.22M |
|
| Cash Flow Statement Financials | |
$-129.06M |
|
$-122.83M |
|
$280.12M |
|
$23.02M |
|
$51.25M |
|
$28.23M |
|
$22.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-24486.27% |
|
-24486.26% |
|
-- |
|
-22687.32% |
|
-22687.32% |
|
$-129.27M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
|
Receiveable Turnover |
5.46 |
16.48 |
|
-13.06% |
|
-13.06% |
|
-12.14% |
|
-13.06% |
|
$11.42 |
|
$-3.35 |
|
$-3.34 |
|